SEC Company Response from Nanobiotix S.A. (NBTX) (CIK 0001760854) (NBTX) — Dec 8, 2020
Nanobiotix S.A. (NBTX) (CIK 0001760854)
Date: Dec. 8, 2020 · CIK: 0001760854 · Accession: 0001140361-20-027623
AI Filing Summary & Sentiment
File numbers found in text: 333-250707
Letter
Nanobiotix S.A.
60, rue de Wattignies
75012 Paris, France
December 8, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention:
David Burton
Kate Tillan
Laura Crotty
Dorrie Yale
RE: Nanobiotix S.A.
Registration Statement on Form F-1 (File No. 333-250707)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Nanobiotix S.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on December 10, 2020 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes Peter Devlin, an attorney with our legal counsel, Jones Day, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm the event with Peter Devlin of Jones Day at 212-326-3978. Thank you for your attention to this matter.
Very truly yours,
NANOBIOTIX S.A.
Show Raw Text
CORRESP
1
filename1.htm
Nanobiotix S.A.
60, rue de Wattignies
75012 Paris, France
December 8, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention:
David Burton
Kate Tillan
Laura Crotty
Dorrie Yale
RE: Nanobiotix S.A.
Registration Statement on Form F-1 (File No. 333-250707)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Nanobiotix S.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the
above-referenced Registration Statement on Form F-1 to become effective on December 10, 2020 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes Peter Devlin, an attorney with our legal counsel, Jones
Day, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm the event with Peter Devlin of Jones Day at 212-326-3978. Thank you for
your attention to this matter.
Very truly yours,
NANOBIOTIX S.A.
By:
/s/ Laurent Levy
Laurent Levy, Ph.D.
Chief Executive Officer
cc:
Peter Devlin, Jones Day